Hakan Oral is a Cardiology physician affiliated with University of Michigan. OpenAlex indexes 448 publications with 25,747 citations (h-index 79); ClinicalTrials.gov lists 4 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Clinical Cardiac Electrophysiology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1500 East Medical Center Dr
3rd Floor Cardiovascular Center
Ann Arbor, MI 481095856
Telephone
888-287-1082Registry record last updated 27 Mar 2012.
Clinical trials
- Metformin as an Adjunctive Therapy to Catheter Ablation in Atrial Fibrillation
Sponsor: University of Michigan
- Telemedicine Enabling Patients in Self-care Behaviors
Sponsor: University of Michigan
- Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation
Sponsor: University of Michigan
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20241 payment
- Boston Scientific CorporationProgram year20231 payment
- Siemens Medical Solutions USA, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
57%Beta blocker33%Metoprolol Succinate79%Metoprolol Tartrate13%Sotalol5%Carvedilol3%Part D<11 patientsAntiarrhythmic21.2%Amiodarone Hcl37%Flecainide Acetate20%Dofetilide16%Propafenone Hcl Er16%Propafenone Hcl12%Part D≥43 patients+ 1 more class in this area
Blood & clotting
38.6%Factor Xa inhibitor32.4%Eliquis89%Xarelto11%Part D≥102 patientsVitamin K antagonist3.3%Warfarin Sodium100%Part D≥13 patients+ 1 more class in this area
Metabolism & gastrointestinal
4.4%Proton pump inhibitor3.2%Omeprazole100%Part D≥35 patientsCorticosteroid1.2%Prednisone100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2026–2026 per NIH RePORTER. The latest:
- CardioExcyte 96: High-Throughput, Non-Invasive Platform for Cardiac Electrophysiology and Toxicology
University of Michigan at Ann Arbor
FY2026$148,085S10OD040108
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Genome-wide Study of Atrial Fibrillation Identifies Seven Risk Loci and Highlights Biological Pathways and Regulatory Elements Involved in Cardiac Development
The American Journal of Human Genetics
2017 - Galectin-3 Regulates Atrial Fibrillation Remodeling and Predicts Catheter Ablation Outcomes
JACC Basic to Translational Science
2016 - An Injectable 64 nW ECG Mixed-Signal SoC in 65 nm for Arrhythmia Monitoring
IEEE Journal of Solid-State Circuits
2014 - Effects of Sex on the Incidence of Cardiac Tamponade After Catheter Ablation of Atrial Fibrillation
Circulation Arrhythmia and Electrophysiology
2014
Similar KOLs
Other experts from the same institution or the same specialty.
Moshe Talpaz, MD
University of Michigan
William Herman, MD
University of Michigan
Max Wicha, MD
University of Michigan
Dinesh Khanna, MD
University of Michigan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”